BioActor

company

About

BioActor develops proprietary health ingredients for use in functional foods, medical nutrition, and dietary supplements.

  • 1 - 10

Details

Last Funding Type
Series A
Last Funding Money Raised
€2M
Industries
Biotechnology,Dietary Supplements,Health Care
Founded date
Jan 1, 2005
Number Of Employee
1 - 10
Operating Status
Active

BioActor develops proprietary health ingredients for use in functional foods, medical nutrition and dietary supplements. All these ingredients address chronic health concerns, such as diabetes,osteoporosis, cardiovascular disease, that would benefit from preventative measures through the diet. BioActor's product development strategy relies on three simple tenets: a new health ingredient must be based on a patentable scientific discovery; it must be food grade from a natural and renewable source; and its health effect must be clinically proven. BioActor's first product, BONOLIVE, a first in class bone health ingredient that is clinically proven to stimulate bone producing cells, is a great example of this strategy and will be launched in the USA this year. BioActor successfully implemented its product development strategy by establishing alliances with top nutrition research institutes (e.g. INRA, CSIC, Maastricht University, UCL, Ghent University) and by establishing production partnerships with industrial players to shorten the path to market.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
€2M
BioActor has raised a total of €2M in funding over 2 rounds. Their latest funding was raised on Jul 26, 2011 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 26, 2011 Series A €2M 2 Detail

Investors

Number of Lead Investors
Number of Investors
2
BioActor is funded by 2 investors. Nedermaas Hightech Ventures and Limburg Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Nedermaas Hightech Ventures Series A
Limburg Ventures Series A